首页 > 最新文献

Neurourology and Urodynamics最新文献

英文 中文
Automated Ultrasound-Based Analysis of Urethral Kinematics in Stress Urinary Incontinence: A Pilot Study. 压力性尿失禁尿道运动学的自动超声分析:一项初步研究。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-09 DOI: 10.1002/nau.70231
Kourosh Kalayeh, J Brian Fowlkes, Stephanie Daignault-Newton, Payton Schmidt, James A Ashton-Miller, John O DeLancey

Objectives: Stress urinary incontinence (SUI) has been linked to excessive urethral mobility, yet clinical evaluation has been largely limited to assessing maximal excursion rather than capturing the full dynamics of visible urethral movement. In this study, we hypothesize that an automated, ultrasound-based method can objectively differentiate urethral mobility patterns between women with SUI and continent controls.

Methods: We used a previously validated optical flow-based algorithm to automatically track urethral motion from transperineal ultrasound images during cough, Valsalva maneuver, and pelvic muscle contraction (PMC) in 11 women with SUI and 10 continent controls. Urethral motion was assessed by defining three regions of interest along the urethra (proximal, mid, and distal). Segmental urethral kinematics were computed and statistically compared between groups.

Results: Substantial variability and overlap between groups were observed, with coefficient of variation ranging 25%-90%. On average, women with SUI demonstrated significantly larger urethral displacement compared to controls, particularly at the proximal segment during Valsalva (10.6 ± 1.2 mm vs. 6.0 ± 0.6 mm, p < 0.01), with pronounced inferior-posterior motion. Additionally, displacement between the upper and lower urethra was significantly larger in the SUI group (0.47 ± 0.10 mm/mm vs. 0.13 ± 0.03 mm/mm, p < 0.05), indicating localized hypermobility particularly near the proximal urethra. Maneuver-specific differences were also noted within the SUI group, with Valsalva producing significantly larger and less uniform urethral movements compared to cough (10.6 ± 1.2 mm vs. 6.6 ± 0.5 mm, p < 0.05).

Conclusion: Our results demonstrate that the automated method is capable of capturing urethral mobility characteristics associated with SUI. Significant inter-individual variability in both continent and SUI groups indicates that urethral kinematics are heterogeneous. The detailed kinematic data have the potential to identify distinct sub-types of urethral mobility, facilitating systematic comparisons with underlying structural and neuromuscular defects. This approach can move clinical evaluation from simple group comparisons toward personalized SUI diagnosis and targeted treatment selection. Future studies with larger sample sizes and inclusion of additional pelvic floor conditions will be needed to validate these findings and advance their translation into clinical practice.

目的:压力性尿失禁(SUI)与过度尿道活动有关,但临床评估主要局限于评估最大偏移,而不是捕捉可见尿道运动的全部动态。在这项研究中,我们假设一种自动化的、基于超声波的方法可以客观地区分SUI女性和大陆对照组的尿道活动模式。方法:我们使用先前验证的基于光流的算法,从11名SUI女性和10名大陆对照组的咳嗽、Valsalva手法和骨盆肌肉收缩(PMC)期间的会阴超声图像自动跟踪尿道运动。通过定义沿尿道的三个感兴趣区域(近端、中端和远端)来评估尿道运动。计算两组间尿道节段运动规律并进行统计学比较。结果:组间存在较大的变异和重叠,变异系数在25% ~ 90%之间。平均而言,与对照组相比,患有SUI的女性表现出更大的尿道移位,特别是在Valsalva期间的近端段(10.6±1.2 mm对6.0±0.6 mm)。结论:我们的结果表明,自动化方法能够捕捉与SUI相关的尿道移动特征。大陆组和SUI组显著的个体间变异表明尿道运动学是异质的。详细的运动学数据有可能识别尿道活动的不同亚型,促进与潜在结构和神经肌肉缺陷的系统比较。这种方法可以将临床评估从简单的组比较转向个性化SUI诊断和有针对性的治疗选择。未来的研究需要更大的样本量和包括额外的盆底疾病来验证这些发现,并将其转化为临床实践。
{"title":"Automated Ultrasound-Based Analysis of Urethral Kinematics in Stress Urinary Incontinence: A Pilot Study.","authors":"Kourosh Kalayeh, J Brian Fowlkes, Stephanie Daignault-Newton, Payton Schmidt, James A Ashton-Miller, John O DeLancey","doi":"10.1002/nau.70231","DOIUrl":"https://doi.org/10.1002/nau.70231","url":null,"abstract":"<p><strong>Objectives: </strong>Stress urinary incontinence (SUI) has been linked to excessive urethral mobility, yet clinical evaluation has been largely limited to assessing maximal excursion rather than capturing the full dynamics of visible urethral movement. In this study, we hypothesize that an automated, ultrasound-based method can objectively differentiate urethral mobility patterns between women with SUI and continent controls.</p><p><strong>Methods: </strong>We used a previously validated optical flow-based algorithm to automatically track urethral motion from transperineal ultrasound images during cough, Valsalva maneuver, and pelvic muscle contraction (PMC) in 11 women with SUI and 10 continent controls. Urethral motion was assessed by defining three regions of interest along the urethra (proximal, mid, and distal). Segmental urethral kinematics were computed and statistically compared between groups.</p><p><strong>Results: </strong>Substantial variability and overlap between groups were observed, with coefficient of variation ranging 25%-90%. On average, women with SUI demonstrated significantly larger urethral displacement compared to controls, particularly at the proximal segment during Valsalva (10.6 ± 1.2 mm vs. 6.0 ± 0.6 mm, p < 0.01), with pronounced inferior-posterior motion. Additionally, displacement between the upper and lower urethra was significantly larger in the SUI group (0.47 ± 0.10 mm/mm vs. 0.13 ± 0.03 mm/mm, p < 0.05), indicating localized hypermobility particularly near the proximal urethra. Maneuver-specific differences were also noted within the SUI group, with Valsalva producing significantly larger and less uniform urethral movements compared to cough (10.6 ± 1.2 mm vs. 6.6 ± 0.5 mm, p < 0.05).</p><p><strong>Conclusion: </strong>Our results demonstrate that the automated method is capable of capturing urethral mobility characteristics associated with SUI. Significant inter-individual variability in both continent and SUI groups indicates that urethral kinematics are heterogeneous. The detailed kinematic data have the potential to identify distinct sub-types of urethral mobility, facilitating systematic comparisons with underlying structural and neuromuscular defects. This approach can move clinical evaluation from simple group comparisons toward personalized SUI diagnosis and targeted treatment selection. Future studies with larger sample sizes and inclusion of additional pelvic floor conditions will be needed to validate these findings and advance their translation into clinical practice.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sagittal Double-Hump Deformity of the Lumbosacral Spine: An Anatomical Risk Factor for Surgical Landmark Obscuration During Laparoscopic Sacrocolpopexy. 腰骶椎矢状双驼峰畸形:腹腔镜骶骶固定术中手术地标遮挡的解剖学危险因素。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-09 DOI: 10.1002/nau.70228
Hirotaka Sato, Miki Kurita, Hirokazu Abe, Shota Otsuka, Sachiyuki Tsukada

Objective: This prospective study evaluated the impact of the "double-hump" deformity-defined by anterior protrusions of the L4-L5 and L5-S1 disks-on L5-S1 angulation and laparoscopic sacrocolpopexy (LSC) outcomes. We hypothesized that this deformity is associated with reduced angulation and impaired sacral promontory visibility.

Methods: The L5-S1 intervertebral angle measured using sagittal computed tomography (CT) was the primary outcome. Intraoperative sacral promontory visibility, postoperative CT findings of mesh malposition, and perioperative surgical measures (operative time, blood loss) were key secondary outcomes. A total of 184 women scheduled to undergo LSC underwent preoperative CT. The double-hump deformity was defined as an L4-L5 angle > 15° and an L5-S1 angle < 50°. CT measurements of disk heights, disk angles, and sacral promontory location were obtained. For double-hump cases (n = 52), intraoperative videos were reviewed by a blinded surgeon who scored sacral promontory visibility. Postoperative CT was performed to assess mesh placement.

Results: Compared with the control group, the double-hump group had a significantly smaller L5-S1 angle and greater L4-L5 angle (primary outcome). In 50% of double-hump cases (secondary outcome), sacral promontory visualization was rated as "difficult." Intervertebral fixation was not identified by postoperative CT. Estimated blood loss in the double-hump group was greater than that in the control group.

Conclusions: The double-hump deformity is associated with reduced L5-S1 angulation, spinal degeneration, and impaired landmark visibility during LSC. Preoperative recognition may facilitate surgical planning and improve intraoperative safety.

目的:本前瞻性研究评估“双驼峰”畸形(由L4-L5和L5-S1椎间盘前突定义)对L5-S1成角和腹腔镜骶colpop固定术(LSC)结果的影响。我们假设这种畸形与角度降低和骶骨角可见性受损有关。方法:以矢状位CT测量L5-S1椎间角为主要观察指标。术中骶骨角的可见度、术后补片错位的CT表现和围手术期的手术措施(手术时间、出血量)是关键的次要结局。184名计划行LSC的妇女术前行CT检查。双驼峰畸形定义为L4-L5角bbb15°和L5-S1角结果:与对照组相比,双驼峰组L5-S1角明显减小,L4-L5角明显增大(主要结果)。在50%的双驼峰病例(次要结果)中,骶骨角的可视化被评为“困难”。术后CT未发现椎间固定。双驼峰组的估计失血量大于对照组。结论:双驼峰畸形与LSC期间L5-S1成角降低、脊柱退变和地标性视野受损有关。术前识别有助于手术计划和提高术中安全性。
{"title":"Sagittal Double-Hump Deformity of the Lumbosacral Spine: An Anatomical Risk Factor for Surgical Landmark Obscuration During Laparoscopic Sacrocolpopexy.","authors":"Hirotaka Sato, Miki Kurita, Hirokazu Abe, Shota Otsuka, Sachiyuki Tsukada","doi":"10.1002/nau.70228","DOIUrl":"https://doi.org/10.1002/nau.70228","url":null,"abstract":"<p><strong>Objective: </strong>This prospective study evaluated the impact of the \"double-hump\" deformity-defined by anterior protrusions of the L4-L5 and L5-S1 disks-on L5-S1 angulation and laparoscopic sacrocolpopexy (LSC) outcomes. We hypothesized that this deformity is associated with reduced angulation and impaired sacral promontory visibility.</p><p><strong>Methods: </strong>The L5-S1 intervertebral angle measured using sagittal computed tomography (CT) was the primary outcome. Intraoperative sacral promontory visibility, postoperative CT findings of mesh malposition, and perioperative surgical measures (operative time, blood loss) were key secondary outcomes. A total of 184 women scheduled to undergo LSC underwent preoperative CT. The double-hump deformity was defined as an L4-L5 angle > 15° and an L5-S1 angle < 50°. CT measurements of disk heights, disk angles, and sacral promontory location were obtained. For double-hump cases (n = 52), intraoperative videos were reviewed by a blinded surgeon who scored sacral promontory visibility. Postoperative CT was performed to assess mesh placement.</p><p><strong>Results: </strong>Compared with the control group, the double-hump group had a significantly smaller L5-S1 angle and greater L4-L5 angle (primary outcome). In 50% of double-hump cases (secondary outcome), sacral promontory visualization was rated as \"difficult.\" Intervertebral fixation was not identified by postoperative CT. Estimated blood loss in the double-hump group was greater than that in the control group.</p><p><strong>Conclusions: </strong>The double-hump deformity is associated with reduced L5-S1 angulation, spinal degeneration, and impaired landmark visibility during LSC. Preoperative recognition may facilitate surgical planning and improve intraoperative safety.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between Urinary Caffeine With Caffeine Metabolites and Wet Overactive Bladder: A Cross-Sectional Study From NHANES 2009-2014 Data. 尿中咖啡因与咖啡因代谢物与湿性过动膀胱的关系:来自NHANES 2009-2014数据的横断面研究
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-09 DOI: 10.1002/nau.70232
Junjie Ji, Gongyue Liu, Guoqing Chen, Yi Gao, Zhonghan Zhou, Limin Liao

Background: The potential relationship between urinary caffeine metabolites and wet overactive bladder (OAB) is not clear. This study aims to investigate the relationship between urinary caffeine with caffeine metabolites and wet OAB prevalence in American population.

Methods: This cross-sectional study included participants from the National Health and Nutrition Examination Survey (NHANES) between 2009 and 2014. Diagnosis of wet OAB, urinary caffeine with caffeine metabolites, and covariates including demographic, dietary, examination, laboratory, and questionnaire data were collected. Weighted univariate analysis, weighted multivariate logistic regression analysis, restricted cubic spline (RCS) analysis, and subgroup analysis were used to investigate the relationship between urinary caffeine with 14 caffeine metabolites and wet OAB. Two sensitivity analyses were performed to test the stability of our results.

Results: Three thousand three hundred and ninety five participants (362 wet OAB and 3033 non-wet OAB) were finally enrolled for analyses. Caffeine intake was not associated with wet OAB (p = 0.455). While multivariate logistic regression analyses and RCS analyses which adjusted all covariates showed that increasing 1,7-dimethyluric acid (odds ratio [OR] = 0.998, 95% confidence interval [CI]: 0.996-0.999, p = 0.015), 1,3,7-trimethyluric acid (OR = 0.954, 95% CI: 0.925-0.984, p = 0.005), paraxanthine (OR = 0.994, 95% CI: 0.989-1.000, p = 0.045), theobromine (OR = 0.994, 95% CI: 0.988-0.999, p = 0.033), and caffeine (OR = 0.974, 95% CI: 0.960-0.989, p = 0.002) were linearly significantly related to decreased risk of wet OAB. Subgroup analyses showed significant negative associations to wet OAB in specific groups of these five metabolites. Sensitivity analyses confirmed the stability. The increased caffeine to 1,3,7-trimethyluric acid, caffeine to 1,7-dimethyluric acid pathway, and caffeine to theobromine pathways might be related to lower risk of wet OAB.

Conclusions: We found no direct link between caffeine intake and wet OAB, but identified linear negative associations of urinary caffeine and several caffeine metabolites with wet OAB, which might be related to the change caffeine metabolic pathway.

背景:尿中咖啡因代谢物与湿性膀胱过动症(OAB)之间的潜在关系尚不清楚。本研究旨在探讨美国人群尿中咖啡因与咖啡因代谢物和湿性OAB患病率之间的关系。方法:本横断面研究纳入了2009年至2014年国家健康与营养检查调查(NHANES)的参与者。收集湿性OAB的诊断、尿中含咖啡因代谢物的咖啡因以及包括人口统计学、饮食、检查、实验室和问卷调查数据在内的协变量。采用加权单因素分析、加权多因素logistic回归分析、限制性三次样条(RCS)分析和亚组分析探讨尿中咖啡因与14种咖啡因代谢物与湿性OAB的关系。进行了两次敏感性分析以检验结果的稳定性。结果:33,395名参与者(362名湿性OAB和3033名非湿性OAB)最终被纳入分析。咖啡因摄入与湿OAB无关(p = 0.455)。多因素logistic回归分析和调整所有协变量的RCS分析显示,1,7-二甲基尿酸(优势比[OR] = 0.998, 95%可信区间[CI]: 0.996-0.999, p = 0.015)、1,3,7-三甲基尿酸(OR = 0.954, 95% CI: 0.925-0.984, p = 0.005)、副黄嘌呤(OR = 0.994, 95% CI: 0.989-1.000, p = 0.045)、可可碱(OR = 0.994, 95% CI: 0.988-0.999, p = 0.033)和咖啡因(OR = 0.974, 95% CI:0.960 ~ 0.989, p = 0.002)与湿性OAB风险降低呈线性显著相关。亚组分析显示,这五种代谢物的特定组与湿OAB呈显著负相关。敏感性分析证实了该方法的稳定性。增加咖啡因到1,3,7-三甲基尿酸、咖啡因到1,7-二甲基尿酸途径和咖啡因到可可碱途径可能与降低湿性OAB的风险有关。结论:我们没有发现咖啡因摄入与湿性OAB之间的直接联系,但发现尿中咖啡因和几种咖啡因代谢物与湿性OAB呈线性负相关,这可能与咖啡因代谢途径的改变有关。
{"title":"The Relationship Between Urinary Caffeine With Caffeine Metabolites and Wet Overactive Bladder: A Cross-Sectional Study From NHANES 2009-2014 Data.","authors":"Junjie Ji, Gongyue Liu, Guoqing Chen, Yi Gao, Zhonghan Zhou, Limin Liao","doi":"10.1002/nau.70232","DOIUrl":"https://doi.org/10.1002/nau.70232","url":null,"abstract":"<p><strong>Background: </strong>The potential relationship between urinary caffeine metabolites and wet overactive bladder (OAB) is not clear. This study aims to investigate the relationship between urinary caffeine with caffeine metabolites and wet OAB prevalence in American population.</p><p><strong>Methods: </strong>This cross-sectional study included participants from the National Health and Nutrition Examination Survey (NHANES) between 2009 and 2014. Diagnosis of wet OAB, urinary caffeine with caffeine metabolites, and covariates including demographic, dietary, examination, laboratory, and questionnaire data were collected. Weighted univariate analysis, weighted multivariate logistic regression analysis, restricted cubic spline (RCS) analysis, and subgroup analysis were used to investigate the relationship between urinary caffeine with 14 caffeine metabolites and wet OAB. Two sensitivity analyses were performed to test the stability of our results.</p><p><strong>Results: </strong>Three thousand three hundred and ninety five participants (362 wet OAB and 3033 non-wet OAB) were finally enrolled for analyses. Caffeine intake was not associated with wet OAB (p = 0.455). While multivariate logistic regression analyses and RCS analyses which adjusted all covariates showed that increasing 1,7-dimethyluric acid (odds ratio [OR] = 0.998, 95% confidence interval [CI]: 0.996-0.999, p = 0.015), 1,3,7-trimethyluric acid (OR = 0.954, 95% CI: 0.925-0.984, p = 0.005), paraxanthine (OR = 0.994, 95% CI: 0.989-1.000, p = 0.045), theobromine (OR = 0.994, 95% CI: 0.988-0.999, p = 0.033), and caffeine (OR = 0.974, 95% CI: 0.960-0.989, p = 0.002) were linearly significantly related to decreased risk of wet OAB. Subgroup analyses showed significant negative associations to wet OAB in specific groups of these five metabolites. Sensitivity analyses confirmed the stability. The increased caffeine to 1,3,7-trimethyluric acid, caffeine to 1,7-dimethyluric acid pathway, and caffeine to theobromine pathways might be related to lower risk of wet OAB.</p><p><strong>Conclusions: </strong>We found no direct link between caffeine intake and wet OAB, but identified linear negative associations of urinary caffeine and several caffeine metabolites with wet OAB, which might be related to the change caffeine metabolic pathway.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium-Update for Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU). 预防下尿路症状(PLUS)研究联盟-泌尿动力学,女性盆腔医学和泌尿生殖重建学会(SUFU)更新。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-04 DOI: 10.1002/nau.70230
Ariana L Smith, Siobhan Sutcliffe

The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has had a successful and productive ten years, accomplishing several major achievements, including over 65 peer-reviewed publications. This multicenter, transdisciplinary Consortium developed the concept of bladder health and studied it systematically in RISE FOR HEALTH (RISE). The resources developed and the data generated will be made available for use through the NIDDK repository, providing the content for many more accomplishments in the field of bladder health. Clinical Trial Registration: NCT05365971.

下尿路症状预防(PLUS)研究联盟在国家糖尿病、消化和肾脏疾病研究所(NIDDK)的支持下,已经有了成功和富有成效的十年,取得了几项重大成就,包括超过65篇同行评议的出版物。这个多中心、跨学科的联盟提出了膀胱健康的概念,并在RISE FOR health (RISE FOR health)中进行了系统的研究。开发的资源和产生的数据将通过国家膀胱健康数据库提供,为膀胱健康领域的更多成就提供内容。临床试验注册:NCT05365971。
{"title":"Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium-Update for Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).","authors":"Ariana L Smith, Siobhan Sutcliffe","doi":"10.1002/nau.70230","DOIUrl":"https://doi.org/10.1002/nau.70230","url":null,"abstract":"<p><p>The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has had a successful and productive ten years, accomplishing several major achievements, including over 65 peer-reviewed publications. This multicenter, transdisciplinary Consortium developed the concept of bladder health and studied it systematically in RISE FOR HEALTH (RISE). The resources developed and the data generated will be made available for use through the NIDDK repository, providing the content for many more accomplishments in the field of bladder health. Clinical Trial Registration: NCT05365971.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Are the Limitations of Measuring Bladder Compliance, As the Sole Indicator of Future Risk to the Upper Urinary Tract and Renal Function? ICI-RS 2025. 测量膀胱顺应性作为未来上尿路和肾功能风险的唯一指标有什么局限性?ICI-RS 2025。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-04 DOI: 10.1002/nau.70236
Eric Rovner, Marcus J Drake, Solomon Eskinder, Andrew Gammie, Sanjay Sinha, John Speich

Introduction: Maintenance of bladder filling and urinary storage at low intravesical pressures is fundamental to minimizing risk to the upper urinary tract. Bladder compliance describes the relationship between the bladder volume and the change in detrusor pressure during the filling phase of urodynamics. Although significant clinical studies were performed 40 years ago, as currently conceived, the concept of bladder compliance and the associated normative values are inexact as an isolated measurement in predicting upper urinary tract deterioration in individual patients. The purpose of this review is to better define some of these limitations and propose potential means of addressing them.

Methods: The ICI-RS meeting was held in Bristol, England in June 2025, and Proposal 4 reviewed the current limitations of measuring bladder compliance as a predictor of upper urinary tract deterioration. Several ideas were discussed regarding the existing shortcomings of this parameter as well as potential methods of improving its measurement and prognostic value. Future research questions were reviewed and prioritized.

Results: The current methods of measurement and normative values for bladder compliance are inadequate for assessing upper urinary tract risk in many patients. The urodynamic technique for assessing compliance is not standardized among investigators resulting in potential variances between patients and centres. In addition, many patients undergoing urodynamics have very abnormal lower urinary tract anatomy. Such differences in structure, if not accounted for, could impact compliance assessment. Finally, the current "gold standard" of assessing compliance, the pressure-flow urodynamic study, involves catheters and is expensive, and itself may not account for a number of other factors which could potentially affect upper urinary tract risk. Alternative methods of assessing bladder compliance and upper urinary tract risk are investigational but may have some improved prognostic value.

Conclusions: Prediciting upper urinary tract deterioration due to abnormalities of bladder compliance remains inexact as an isolated metric. The reasons for the lack of sensitivity and specificity are not well understood. Identifying the limitations of bladder compliance, modifying its assessment or combining it with other clinical or biological measurements may provide better and more precise prognostic information. In the meantime, advice is given on a "common sense" way by which UDS can be modified in relevant patient, in order to provide information that improves management and surveillance of vulnerable patients at risk from renal damage.

在低膀胱内压力下维持膀胱充盈和尿潴留是减少上尿路风险的基础。膀胱顺应性描述尿动力学充盈期膀胱体积与逼尿肌压力变化之间的关系。尽管40年前就进行了重要的临床研究,但目前认为,膀胱顺应性的概念和相关的规范性值作为预测单个患者上尿路恶化的孤立测量是不准确的。本综述的目的是更好地定义其中的一些限制,并提出解决这些限制的潜在方法。方法:ICI-RS会议于2025年6月在英国布里斯托尔举行,提案4回顾了目前测量膀胱顺应性作为上尿路恶化预测指标的局限性。讨论了该参数存在的缺点,以及改进其测量和预测价值的潜在方法。对未来的研究问题进行了回顾和排序。结果:目前膀胱顺应性的测量方法和规范值不足以评估许多患者的上尿路风险。评估依从性的尿动力学技术在研究者之间没有标准化,导致患者和中心之间存在潜在差异。此外,许多接受尿动力学治疗的患者下尿路解剖结构非常异常。这种结构上的差异,如果不加以考虑,可能会影响合规性评估。最后,目前评估依从性的“金标准”,即压力-流量尿动力学研究,涉及到导尿管,而且价格昂贵,而且本身可能无法考虑到可能影响上尿路风险的许多其他因素。评估膀胱顺应性和上尿路风险的替代方法仍在研究中,但可能有一些改善的预后价值。结论:预测由于膀胱顺应性异常引起的上尿路恶化作为一个孤立的指标仍然不准确。缺乏敏感性和特异性的原因尚不清楚。确定膀胱顺应性的局限性,修改其评估或将其与其他临床或生物学测量相结合,可以提供更好和更准确的预后信息。与此同时,还就如何在相关患者中修改UDS的“常识性”方法提出了建议,以便提供信息,改善对有肾损害风险的脆弱患者的管理和监测。
{"title":"What Are the Limitations of Measuring Bladder Compliance, As the Sole Indicator of Future Risk to the Upper Urinary Tract and Renal Function? ICI-RS 2025.","authors":"Eric Rovner, Marcus J Drake, Solomon Eskinder, Andrew Gammie, Sanjay Sinha, John Speich","doi":"10.1002/nau.70236","DOIUrl":"https://doi.org/10.1002/nau.70236","url":null,"abstract":"<p><strong>Introduction: </strong>Maintenance of bladder filling and urinary storage at low intravesical pressures is fundamental to minimizing risk to the upper urinary tract. Bladder compliance describes the relationship between the bladder volume and the change in detrusor pressure during the filling phase of urodynamics. Although significant clinical studies were performed 40 years ago, as currently conceived, the concept of bladder compliance and the associated normative values are inexact as an isolated measurement in predicting upper urinary tract deterioration in individual patients. The purpose of this review is to better define some of these limitations and propose potential means of addressing them.</p><p><strong>Methods: </strong>The ICI-RS meeting was held in Bristol, England in June 2025, and Proposal 4 reviewed the current limitations of measuring bladder compliance as a predictor of upper urinary tract deterioration. Several ideas were discussed regarding the existing shortcomings of this parameter as well as potential methods of improving its measurement and prognostic value. Future research questions were reviewed and prioritized.</p><p><strong>Results: </strong>The current methods of measurement and normative values for bladder compliance are inadequate for assessing upper urinary tract risk in many patients. The urodynamic technique for assessing compliance is not standardized among investigators resulting in potential variances between patients and centres. In addition, many patients undergoing urodynamics have very abnormal lower urinary tract anatomy. Such differences in structure, if not accounted for, could impact compliance assessment. Finally, the current \"gold standard\" of assessing compliance, the pressure-flow urodynamic study, involves catheters and is expensive, and itself may not account for a number of other factors which could potentially affect upper urinary tract risk. Alternative methods of assessing bladder compliance and upper urinary tract risk are investigational but may have some improved prognostic value.</p><p><strong>Conclusions: </strong>Prediciting upper urinary tract deterioration due to abnormalities of bladder compliance remains inexact as an isolated metric. The reasons for the lack of sensitivity and specificity are not well understood. Identifying the limitations of bladder compliance, modifying its assessment or combining it with other clinical or biological measurements may provide better and more precise prognostic information. In the meantime, advice is given on a \"common sense\" way by which UDS can be modified in relevant patient, in order to provide information that improves management and surveillance of vulnerable patients at risk from renal damage.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verbal Versus Structured Education Impact on Anxiety and Satisfaction During Uroflowmetry: A RCT. 语言与结构化教育对尿流测量中焦虑和满意度的影响:一项随机对照试验。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-04 DOI: 10.1002/nau.70233
Ramna Nadeem, Nuzhat Faruqui, Muhammad Hummam Siddique, Noor Ul Ain Zehra, Yasir Rasheed, Sajida Chagani, Hammad Ather

Background: Uroflowmetry (UFM) is a simple and widely used first-line investigation for evaluating lower urinary tract symptoms (LUTS). Despite its non-invasive nature, uroflowmetry can provoke anxiety and affect satisfaction, often due to a lack of understanding about the procedure.

Objective: This randomized controlled trial aimed to compare the effects of structured versus verbal education on alleviating anxiety and assessing patient satisfaction in those undergoing UFM.

Methodology: A single-blind, parallel-arm study was conducted with 148 patients who were randomly assigned to either a structured teaching (brochure) group or a verbal counseling group. The modified Amsterdam Preoperative Anxiety and Information Scale (APAIS-M) was used to assess anxiety, while satisfaction was measured using a validated questionnaire. Descriptive statistics, Chi-square, and independent t-tests were employed for data analysis.

Results: The structured education group demonstrated statistically insignificant overall anxiety score in both groups 10.6 ± 1.23 versus 9.61 ± 1.4 (p = 0.49) in verbally counseled versus structured education group respectively, but individual components have significant differences like worry scores (2.87 ± 0.135) in structured education group compared to the verbal education group (3.49 ± 0.142; p = 0.028), and fewer thoughts (2.90 ± 0.150) versus the verbal education group (3.25 ± 0.155; p = 0.044). Satisfaction scores showed that the structured group had a higher satisfaction to the knowledge provided (1.21 ± 0.04 vs. 1.08 ± 0.036, p = 0.035) and ease of using UFM equipment (4.51 ± 0.11 vs. 4.05 ± 0.118, p = 0.047), more satisfied with aspects related to privacy (4.68 ± 0.112 vs. 4.20 ± 0.115, p = 0.04).

Conclusions: Structured education significantly improved patient understanding, comfort, and expectations regarding privacy, while reducing anxiety compared to verbal counseling. Integrating structured education before uroflowmetry could further enhance the patient experience and satisfaction.

背景:尿流法(UFM)是一种简单且广泛用于评估下尿路症状(LUTS)的一线调查方法。尽管尿流测量是非侵入性的,但由于缺乏对操作的理解,尿流测量可能会引起焦虑并影响满意度。目的:本随机对照试验旨在比较结构化教育和语言教育在缓解UFM患者焦虑和评估患者满意度方面的效果。方法:对148名患者进行了一项单盲、平行研究,这些患者被随机分配到结构化教学(小册子)组或口头咨询组。采用改良的阿姆斯特丹术前焦虑与信息量表(APAIS-M)评估焦虑,采用有效问卷测量满意度。采用描述性统计、卡方检验和独立t检验进行数据分析。结果:结构化教育组两组焦虑总分分别为10.6±1.23分与9.61±1.4分(p = 0.49),差异均无统计学意义,但单项焦虑得分(2.87±0.135分)与言语教育组(3.49±0.142分,p = 0.028)、思想得分(2.90±0.150分)较言语教育组(3.25±0.155分)差异有统计学意义;p = 0.044)。满意度得分显示,结构化组对所提供知识的满意度(1.21±0.04比1.08±0.036,p = 0.035)和UFM设备使用的便利性(4.51±0.11比4.05±0.118,p = 0.047)更高,对隐私相关方面的满意度(4.68±0.112比4.20±0.115,p = 0.04)更高。结论:与口头咨询相比,结构化教育显著提高了患者对隐私的理解、舒适度和期望,同时减少了焦虑。在尿流测量前整合有组织的教育可以进一步提高患者的体验和满意度。
{"title":"Verbal Versus Structured Education Impact on Anxiety and Satisfaction During Uroflowmetry: A RCT.","authors":"Ramna Nadeem, Nuzhat Faruqui, Muhammad Hummam Siddique, Noor Ul Ain Zehra, Yasir Rasheed, Sajida Chagani, Hammad Ather","doi":"10.1002/nau.70233","DOIUrl":"https://doi.org/10.1002/nau.70233","url":null,"abstract":"<p><strong>Background: </strong>Uroflowmetry (UFM) is a simple and widely used first-line investigation for evaluating lower urinary tract symptoms (LUTS). Despite its non-invasive nature, uroflowmetry can provoke anxiety and affect satisfaction, often due to a lack of understanding about the procedure.</p><p><strong>Objective: </strong>This randomized controlled trial aimed to compare the effects of structured versus verbal education on alleviating anxiety and assessing patient satisfaction in those undergoing UFM.</p><p><strong>Methodology: </strong>A single-blind, parallel-arm study was conducted with 148 patients who were randomly assigned to either a structured teaching (brochure) group or a verbal counseling group. The modified Amsterdam Preoperative Anxiety and Information Scale (APAIS-M) was used to assess anxiety, while satisfaction was measured using a validated questionnaire. Descriptive statistics, Chi-square, and independent t-tests were employed for data analysis.</p><p><strong>Results: </strong>The structured education group demonstrated statistically insignificant overall anxiety score in both groups 10.6 ± 1.23 versus 9.61 ± 1.4 (p = 0.49) in verbally counseled versus structured education group respectively, but individual components have significant differences like worry scores (2.87 ± 0.135) in structured education group compared to the verbal education group (3.49 ± 0.142; p = 0.028), and fewer thoughts (2.90 ± 0.150) versus the verbal education group (3.25 ± 0.155; p = 0.044). Satisfaction scores showed that the structured group had a higher satisfaction to the knowledge provided (1.21 ± 0.04 vs. 1.08 ± 0.036, p = 0.035) and ease of using UFM equipment (4.51 ± 0.11 vs. 4.05 ± 0.118, p = 0.047), more satisfied with aspects related to privacy (4.68 ± 0.112 vs. 4.20 ± 0.115, p = 0.04).</p><p><strong>Conclusions: </strong>Structured education significantly improved patient understanding, comfort, and expectations regarding privacy, while reducing anxiety compared to verbal counseling. Integrating structured education before uroflowmetry could further enhance the patient experience and satisfaction.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of a Nomogram for Predicting Urinary Tract Infection After Urodynamic Study. 尿动力学研究后预测尿路感染的Nomogram发展与验证。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-02 DOI: 10.1002/nau.70229
Omri Schwarztuch Gildor, Elad Yosef, Netanel Levin, Anna Itshak, Rony Vainrib, Amos Neheman, Michael Vainrib

Introduction: The use of antibiotic prophylaxis before urodynamic studies has been debated for a long time, with no clear consensus among international guidelines. Based on identified predictors of urinary tract infection after urodynamic studies, this study aims to develop and internally validate a nomogram to predict post-urodynamic study urinary tract infection and assess its clinical net benefit to support selective antibiotic prophylaxis.

Methods: Multivariable logistic regression identified final predictors; coefficients were converted into a user-friendly nomogram. Performance was evaluated using the area under the receiver operating characteristic curve (ROC-AUC), Brier score, calibration (bootstrap-corrected), and precision-recall AUC (average precision). Decision curve analysis was used to evaluate the clinical net-benefit of the nomogram.

Results: The nomogram includes five routinely available variables: hydronephrosis, neurological lower urinary tract dysfunction, post-void residual volume ≥ 200 mL, age ≥ 70, and the use of an indwelling catheter or performing clean intermittent catheterization. Discrimination was fair (ROC AUC 0.7086). Overall accuracy was good (Brier 0.0180). Calibration showed good agreement after bootstrap correction. Average precision was 0.0508, exceeding the base prevalence. Decision curve analysis demonstrated a positive net benefit relative to both the treat-all and treat-none strategies at low clinical thresholds (<5%).

Conclusion: This simple, well-calibrated nomogram provides individualized post-UDS UTI risk estimates and shows decision-analytic benefit in the stewardship-relevant range. It may help target AP to higher-risk patients while safely reducing unnecessary antibiotics. External validation is warranted.

导言:在尿动力学研究之前使用抗生素预防已经争论了很长时间,在国际指南中没有明确的共识。基于尿动力学研究后确定的尿路感染预测因素,本研究旨在开发并内部验证预测尿动力学研究后尿路感染的nomogram,并评估其临床净收益,以支持选择性抗生素预防。方法:多变量logistic回归确定最终预测因子;系数被转换成一个用户友好的图。使用接收器工作特性曲线下面积(ROC-AUC)、Brier评分、校准(自引导校正)和精密度-召回率AUC(平均精密度)来评估性能。决策曲线分析用于评价nomogram临床净收益。结果:nomogram包括5个常规变量:肾积水、神经性下尿路功能障碍、尿后残留容量≥200 mL、年龄≥70岁、是否使用留置导尿管或进行清洁间歇导尿。歧视是公平的(ROC AUC 0.7086)。总体准确度良好(Brier 0.0180)。自举校正后的校准结果吻合良好。平均精度为0.0508,超过基础患病率。决策曲线分析显示,在低临床阈值下,与全治疗和不治疗策略相比,决策曲线分析显示了正的净收益(结论:这个简单、校准良好的nomogram提供了个性化的uds后UTI风险评估,并显示了在管理相关范围内的决策分析收益。它可能有助于将AP瞄准高风险患者,同时安全地减少不必要的抗生素。外部验证是必要的。
{"title":"Development and Validation of a Nomogram for Predicting Urinary Tract Infection After Urodynamic Study.","authors":"Omri Schwarztuch Gildor, Elad Yosef, Netanel Levin, Anna Itshak, Rony Vainrib, Amos Neheman, Michael Vainrib","doi":"10.1002/nau.70229","DOIUrl":"https://doi.org/10.1002/nau.70229","url":null,"abstract":"<p><strong>Introduction: </strong>The use of antibiotic prophylaxis before urodynamic studies has been debated for a long time, with no clear consensus among international guidelines. Based on identified predictors of urinary tract infection after urodynamic studies, this study aims to develop and internally validate a nomogram to predict post-urodynamic study urinary tract infection and assess its clinical net benefit to support selective antibiotic prophylaxis.</p><p><strong>Methods: </strong>Multivariable logistic regression identified final predictors; coefficients were converted into a user-friendly nomogram. Performance was evaluated using the area under the receiver operating characteristic curve (ROC-AUC), Brier score, calibration (bootstrap-corrected), and precision-recall AUC (average precision). Decision curve analysis was used to evaluate the clinical net-benefit of the nomogram.</p><p><strong>Results: </strong>The nomogram includes five routinely available variables: hydronephrosis, neurological lower urinary tract dysfunction, post-void residual volume ≥ 200 mL, age ≥ 70, and the use of an indwelling catheter or performing clean intermittent catheterization. Discrimination was fair (ROC AUC 0.7086). Overall accuracy was good (Brier 0.0180). Calibration showed good agreement after bootstrap correction. Average precision was 0.0508, exceeding the base prevalence. Decision curve analysis demonstrated a positive net benefit relative to both the treat-all and treat-none strategies at low clinical thresholds (<5%).</p><p><strong>Conclusion: </strong>This simple, well-calibrated nomogram provides individualized post-UDS UTI risk estimates and shows decision-analytic benefit in the stewardship-relevant range. It may help target AP to higher-risk patients while safely reducing unnecessary antibiotics. External validation is warranted.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146106588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Evidence Do We Need to Improve the Attainment of Bladder and Bowel Control in Children and Prevent Negative Sequelae in Adolescence and Adult Life? ICI-RS 2025. 我们需要哪些证据来改善儿童的膀胱和肠道控制,并预防青少年和成人生活中的负面后遗症?ICI-RS 2025。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-02 DOI: 10.1002/nau.70219
Alexander von Gontard, Giovanni Mosiello, Tufan Tarcan, Mauro van den Ende, Gommert van Koeveringe, Carol Joinson

Aims: Nocturnal enuresis (NE), daytime urinary incontinence (DUI), and fecal incontinence (FI) and functional constipation (FC) are common functional disorders in childhood, which can persist into adolescence and adulthood. The aim of this paper is to review evidence of risk factors that impede the attainment of bladder/bowel control and contribute towards the persistence of incontinence, and to outline protective factors towards minimizing long-term negative sequelae.

Methods: A think tank group consisting of multidisciplinary experts at the International Consultation on Incontinence Research Society (ICI-RS) in 2025 reviewed evidence of factors influencing the attainment of bladder and bowel control, the continuation of incontinence into adolescence and adulthood and the subsequent negative sequelae. Both prospective and retrospective views were considered. Open questions and future directions were discussed. Recommendations for future research and for the improvement of clinical practice in in children, adolescents and adults were formulated.

Results: Childhood incontinence can continue into adolescence and adulthood and is associated with medical and mental health risks. Genetic and environmental risk factors have been identified, but their interaction with protective factors has not been studied. Potentially important environmental risks that require further research include late toilet training, prolonged use of disposable diapers, excessive use of digital media and lack of transitional care from pediatric to adult services. Studies on prevention on all levels (universal, selective and indicated) are lacking.

Conclusions: As childhood incontinence is a precursor of adult incontinence in many patients, early preventive measures are needed. Future research should focus on identifying risk and protective factors. Improved collaboration and exchange between pediatric services and adult urology is essential.

目的:夜间遗尿(NE)、日间尿失禁(DUI)、大便失禁(FI)和功能性便秘(FC)是儿童期常见的功能障碍,可持续到青春期和成年期。本文的目的是回顾阻碍膀胱/肠道控制和导致尿失禁持续的危险因素的证据,并概述保护因素以尽量减少长期负面后遗症。方法:由国际失禁研究协会(ICI-RS)的多学科专家组成的智囊团小组于2025年回顾了影响膀胱和肠道控制的因素,失禁持续到青春期和成年期以及随后的负面后遗症的证据。考虑了前瞻性和回顾性的观点。讨论了悬而未决的问题和未来的发展方向。对未来的研究和改进儿童、青少年和成人的临床实践提出了建议。结果:儿童尿失禁可以持续到青春期和成年期,并与医疗和心理健康风险相关。遗传和环境风险因素已经确定,但它们与保护因素的相互作用尚未研究。需要进一步研究的潜在重要环境风险包括:较晚的如厕训练、长期使用一次性尿布、过度使用数字媒体以及缺乏从儿科到成人服务的过渡护理。缺乏关于各级(普遍、选择性和指示性)预防的研究。结论:儿童期尿失禁是成人尿失禁的先兆,需要采取早期预防措施。未来的研究应侧重于识别风险和保护因素。改善儿科服务和成人泌尿外科之间的合作和交流是必不可少的。
{"title":"What Evidence Do We Need to Improve the Attainment of Bladder and Bowel Control in Children and Prevent Negative Sequelae in Adolescence and Adult Life? ICI-RS 2025.","authors":"Alexander von Gontard, Giovanni Mosiello, Tufan Tarcan, Mauro van den Ende, Gommert van Koeveringe, Carol Joinson","doi":"10.1002/nau.70219","DOIUrl":"10.1002/nau.70219","url":null,"abstract":"<p><strong>Aims: </strong>Nocturnal enuresis (NE), daytime urinary incontinence (DUI), and fecal incontinence (FI) and functional constipation (FC) are common functional disorders in childhood, which can persist into adolescence and adulthood. The aim of this paper is to review evidence of risk factors that impede the attainment of bladder/bowel control and contribute towards the persistence of incontinence, and to outline protective factors towards minimizing long-term negative sequelae.</p><p><strong>Methods: </strong>A think tank group consisting of multidisciplinary experts at the International Consultation on Incontinence Research Society (ICI-RS) in 2025 reviewed evidence of factors influencing the attainment of bladder and bowel control, the continuation of incontinence into adolescence and adulthood and the subsequent negative sequelae. Both prospective and retrospective views were considered. Open questions and future directions were discussed. Recommendations for future research and for the improvement of clinical practice in in children, adolescents and adults were formulated.</p><p><strong>Results: </strong>Childhood incontinence can continue into adolescence and adulthood and is associated with medical and mental health risks. Genetic and environmental risk factors have been identified, but their interaction with protective factors has not been studied. Potentially important environmental risks that require further research include late toilet training, prolonged use of disposable diapers, excessive use of digital media and lack of transitional care from pediatric to adult services. Studies on prevention on all levels (universal, selective and indicated) are lacking.</p><p><strong>Conclusions: </strong>As childhood incontinence is a precursor of adult incontinence in many patients, early preventive measures are needed. Future research should focus on identifying risk and protective factors. Improved collaboration and exchange between pediatric services and adult urology is essential.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146106568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravesical Instillation of Hyaluronic Acid (Cystistat) for the Treatment of Category III Prostatitis: A Retrospective Study. 膀胱内灌注透明质酸治疗III类前列腺炎的回顾性研究。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-02 DOI: 10.1002/nau.70237
Wei Wu, Zhen Wang, Bo Wen, Lang Wang, Yong Shi, Yanbin Zhang
<p><strong>Background: </strong>Chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS), classified as National Institutes of Health (NIH) category III prostatitis, is a common urological disorder, accounting for 90%-95% of prostatitis cases. Its pathogenesis involves inflammatory cascades along the bladder-prostate axis, neurogenic inflammation, and impairment of the mucosal barrier. Sodium hyaluronate (Cystistat), a glycosaminoglycan (GAG) layer replenishment agent, has demonstrated efficacy in treating bladder pain syndrome. However, its therapeutic role in CP/CPPS remains underexplored.</p><p><strong>Objective: </strong>This study aimed to evaluate the clinical efficacy of intravesical hyaluronic acid (Cystistat) instillation in patients with CP/CPPS, identify potential predictive factors, and develop a predictive model to support personalized treatment strategies.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 41 patients with CP/CPPS who received intravesical Cystistat between January 2023 and April 2024. NIH Chronic Prostatitis Symptom Index (NIH-CPSI) scores-including total score and subdomains (pain, urinary symptoms, and quality of life)-and visual analog scale (VAS) scores were compared before and after treatment using paired t-tests. Cohen's d was calculated to assess effect size. A treatment response was defined as a Global Response Assessment (GRA) score ≥2. Multivariate logistic regression was used to explore predictors of treatment response. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), with fivefold cross-validation and sensitivity analyses.</p><p><strong>Results: </strong>NIH-CPSI total scores significantly improved following treatment (25.71 ±  2.91 to 19.56 ±  4.28; mean change: -6.15 [95% CI: -7.27 to -5.02]; p < 0.001; Cohen's d  =  1.68). VAS scores also showed significant reduction (7.07 ± 1.07 to 4.16 ± 1.67; mean change: -2.91 [95% CI: -3.36 to -2.46]; p < 0.001; Cohen's d = 2.07). Improvements were observed across all NIH-CPSI subdomains, with the greatest effect noted in the pain domain (Cohen's d = 1.32). Overall, 70.7% of patients achieved a GRA score ≥2. Logistic regression identified that elevated C-reactive protein (CRP) levels (OR = 1.28, 95% CI: 0.90-1.82) were positively associated with response, while longer disease duration (OR = 0.98, 95% CI: 0.94-1.02) and lower maximum urinary flow rate (Qmax) (OR = 0.88, 95% CI: 0.67-1.15) were negatively associated. However, none of these associations reached statistical significance. A model incorporating CRP, disease duration, and Qmax yielded an AUC of 0.76 (cross-validated AUC: 0.73 ± 0.12). Sensitivity analyses confirmed the model's robustness across alternative definitions of treatment success.</p><p><strong>Conclusions: </strong>Intravesical hyaluronic acid (Cystistat) therapy appears to be clinically effective for CP/CPPS, particularly in pain relief and quality-o
背景:慢性非细菌性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)是一种常见的泌尿系统疾病,被美国国立卫生研究院(NIH)列为III类前列腺炎,占前列腺炎病例的90% ~ 95%。其发病机制包括沿膀胱-前列腺轴的炎症级联反应、神经源性炎症和粘膜屏障损伤。透明质酸钠(Cystistat)是一种糖胺聚糖(GAG)层补充剂,已被证明对膀胱疼痛综合征有疗效。然而,其在CP/CPPS中的治疗作用仍未得到充分探讨。目的:本研究旨在评价膀胱内灌注透明质酸(Cystistat)治疗CP/CPPS患者的临床疗效,识别潜在的预测因素,并建立预测模型以支持个性化的治疗策略。方法:回顾性分析2023年1月至2024年4月接受膀胱膀胱消炎治疗的41例CP/CPPS患者。采用配对t检验比较治疗前后的美国国立卫生研究院慢性前列腺炎症状指数(NIH- cpsi)评分(包括总分和子域(疼痛、泌尿系统症状和生活质量))和视觉模拟量表(VAS)评分。计算Cohen's d来评估效应大小。治疗反应定义为总体反应评估(GRA)评分≥2分。采用多因素logistic回归探讨治疗反应的预测因素。使用受试者工作特征曲线下面积(AUC)评估模型性能,并进行五倍交叉验证和灵敏度分析。结果:治疗后NIH-CPSI总分显著提高(25.71± 2.91至19.56± 4.28;平均变化:-6.15 [95% CI: -7.27至-5.02];p结论:膀胱内透明质酸(Cystistat)治疗对CP/CPPS临床有效,特别是在疼痛缓解和生活质量改善方面。CRP水平升高和病程较短的患者可能从这种治疗中获益更多。所得的预测模型为个体化临床决策提供了工具。这些发现间接支持了“膀胱-前列腺轴”假说,表明Cystistat可能通过恢复膀胱粘膜完整性和降低炎症介质活性来减轻盆腔疼痛。未来的前瞻性随机对照试验需要验证这些发现,并进一步阐明潜在的机制。需要进一步的前瞻性、大规模的研究来证实疗效,特别是在oab相关亚型中,并完善预测建模方法。
{"title":"Intravesical Instillation of Hyaluronic Acid (Cystistat) for the Treatment of Category III Prostatitis: A Retrospective Study.","authors":"Wei Wu, Zhen Wang, Bo Wen, Lang Wang, Yong Shi, Yanbin Zhang","doi":"10.1002/nau.70237","DOIUrl":"https://doi.org/10.1002/nau.70237","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS), classified as National Institutes of Health (NIH) category III prostatitis, is a common urological disorder, accounting for 90%-95% of prostatitis cases. Its pathogenesis involves inflammatory cascades along the bladder-prostate axis, neurogenic inflammation, and impairment of the mucosal barrier. Sodium hyaluronate (Cystistat), a glycosaminoglycan (GAG) layer replenishment agent, has demonstrated efficacy in treating bladder pain syndrome. However, its therapeutic role in CP/CPPS remains underexplored.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to evaluate the clinical efficacy of intravesical hyaluronic acid (Cystistat) instillation in patients with CP/CPPS, identify potential predictive factors, and develop a predictive model to support personalized treatment strategies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective analysis was conducted on 41 patients with CP/CPPS who received intravesical Cystistat between January 2023 and April 2024. NIH Chronic Prostatitis Symptom Index (NIH-CPSI) scores-including total score and subdomains (pain, urinary symptoms, and quality of life)-and visual analog scale (VAS) scores were compared before and after treatment using paired t-tests. Cohen's d was calculated to assess effect size. A treatment response was defined as a Global Response Assessment (GRA) score ≥2. Multivariate logistic regression was used to explore predictors of treatment response. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), with fivefold cross-validation and sensitivity analyses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;NIH-CPSI total scores significantly improved following treatment (25.71 ±  2.91 to 19.56 ±  4.28; mean change: -6.15 [95% CI: -7.27 to -5.02]; p &lt; 0.001; Cohen's d  =  1.68). VAS scores also showed significant reduction (7.07 ± 1.07 to 4.16 ± 1.67; mean change: -2.91 [95% CI: -3.36 to -2.46]; p &lt; 0.001; Cohen's d = 2.07). Improvements were observed across all NIH-CPSI subdomains, with the greatest effect noted in the pain domain (Cohen's d = 1.32). Overall, 70.7% of patients achieved a GRA score ≥2. Logistic regression identified that elevated C-reactive protein (CRP) levels (OR = 1.28, 95% CI: 0.90-1.82) were positively associated with response, while longer disease duration (OR = 0.98, 95% CI: 0.94-1.02) and lower maximum urinary flow rate (Qmax) (OR = 0.88, 95% CI: 0.67-1.15) were negatively associated. However, none of these associations reached statistical significance. A model incorporating CRP, disease duration, and Qmax yielded an AUC of 0.76 (cross-validated AUC: 0.73 ± 0.12). Sensitivity analyses confirmed the model's robustness across alternative definitions of treatment success.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Intravesical hyaluronic acid (Cystistat) therapy appears to be clinically effective for CP/CPPS, particularly in pain relief and quality-o","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146106531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sixteen Years of Multinational Experience in Female Genital Fistula Repair: Integrating Traditional and Innovative Surgical Approaches Across 12 Countries. 16年女性生殖瘘管修复的跨国经验:在12个国家整合传统和创新的手术方法。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-02 DOI: 10.1002/nau.70226
M Sherif Mourad, Mariam Malallah, Wally Mahfouz, Ahmed Saafan, Ahmed Farouk, Mohamed Yassin, Mohamed Metwaly, Hassan Shaker

Objectives: To present a 16-year multinational experience of 1185 female genital fistula (FGF) repairs performed by a single surgical team, emphasizing the integration of classical techniques with adjunctive innovations across diverse clinical settings.

Methods: This structured observational study included 1185 FGF repairs conducted from 2009 to 2025 across 12 countries. Data collected included patient demographics, fistula etiology and type, prior repairs, surgical approach, use of adjuncts, and postoperative outcomes. Primary outcomes were anatomical closure and functional recovery. Secondary outcomes included postoperative complications and psychosocial reintegration of the patients into their families and societies.

Results and limitations: Vesicovaginal fistulas accounted for 64% of cases, followed by urethrovaginal (12%) and rectovaginal (11%). Obstetric trauma and iatrogenic injury were the leading causes (59% and 34%, respectively). Fistulas were classified as simple (36%), recurrent (56%), or complex (8%). Overall closure rate was 82%, highest among simple (91%) and primary (85%) cases. Adjuncts such as platelet-rich plasma (PRP), small intestinal submucosa (SIS), fibrin glue, and buccal grafts were used in 71% of complex/recurrent repairs, with a 72% closure rate in this subgroup. Residual incontinence after successful closure of fistula affected 12% of patients, most of whom improved with bulking agents (72%) or pubovaginal slings (91%). Complication rates included urinary tract and wound infections (5%) and recurrence of fistula (18%). Limitations include retrospective design and heterogeneity in adjunct usage. Another main limitation is our follow-up regimen, which was not done by our surgical team in all countries included. Nevertheless, treatment of residual incontinence was not performed solely by our team, and thus this affected success rate of residual incontinence.

Conclusions: Combining traditional surgical methods with adjunctive techniques enables high closure and functional recovery rates in FGF repair, even in low-resource settings. Selective use of adjuncts supports tissue healing in complex cases and may enhance long-term success.

Patient summary: In this multinational study of 1185 FGF surgeries, integrating traditional and innovative techniques led to high closure rates and improved continence and quality of life even in resource-constrained countries.

Clinical registration: This study does not require clinical trial registration as it is an observational, retrospective analysis of anonymized surgical cases (2009-2025).

目的:介绍16年来由一个外科团队完成的1185例女性生殖器瘘(FGF)修复的跨国经验,强调在不同临床环境下经典技术与辅助创新的整合。方法:这项结构化观察性研究包括2009年至2025年在12个国家进行的1185例FGF修复。收集的数据包括患者人口统计学、瘘管病因和类型、既往修复、手术入路、辅助工具的使用和术后结果。主要结果为解剖闭合和功能恢复。次要结局包括术后并发症和患者重返家庭和社会的心理社会。结果与局限性:膀胱阴道瘘占64%,其次是尿道阴道瘘(12%)和直肠阴道瘘(11%)。产科创伤和医源性损伤是主要原因(分别为59%和34%)。瘘管分为单纯性(36%)、复发性(56%)和复合性(8%)。总结扎率为82%,单纯性(91%)和原发性(85%)最高。辅助材料如富血小板血浆(PRP)、小肠粘膜下层(SIS)、纤维蛋白胶和颊移植物用于71%的复杂/复发修复,该亚组的闭合率为72%。12%的患者在成功关闭瘘管后出现残留失禁,其中大多数患者使用膨化剂(72%)或阴阴道吊带(91%)得到改善。并发症发生率包括尿路和伤口感染(5%)和瘘管复发(18%)。局限性包括回顾性设计和辅助使用的异质性。另一个主要限制是我们的随访方案,并不是我们的外科团队在所有纳入的国家都这样做。然而,残余尿失禁的治疗不是由我们的团队单独进行的,因此这影响了残余尿失禁的成功率。结论:将传统手术方法与辅助技术相结合,即使在资源匮乏的情况下,FGF修复的闭合率和功能恢复率也很高。选择性使用辅助材料支持复杂病例的组织愈合,并可能提高长期的成功。患者总结:在这项涉及1185例FGF手术的跨国研究中,即使在资源受限的国家,传统和创新技术的结合也能提高闭合率,改善自理和生活质量。临床注册:本研究不需要临床试验注册,因为它是对匿名手术病例(2009-2025)的观察性回顾性分析。
{"title":"Sixteen Years of Multinational Experience in Female Genital Fistula Repair: Integrating Traditional and Innovative Surgical Approaches Across 12 Countries.","authors":"M Sherif Mourad, Mariam Malallah, Wally Mahfouz, Ahmed Saafan, Ahmed Farouk, Mohamed Yassin, Mohamed Metwaly, Hassan Shaker","doi":"10.1002/nau.70226","DOIUrl":"https://doi.org/10.1002/nau.70226","url":null,"abstract":"<p><strong>Objectives: </strong>To present a 16-year multinational experience of 1185 female genital fistula (FGF) repairs performed by a single surgical team, emphasizing the integration of classical techniques with adjunctive innovations across diverse clinical settings.</p><p><strong>Methods: </strong>This structured observational study included 1185 FGF repairs conducted from 2009 to 2025 across 12 countries. Data collected included patient demographics, fistula etiology and type, prior repairs, surgical approach, use of adjuncts, and postoperative outcomes. Primary outcomes were anatomical closure and functional recovery. Secondary outcomes included postoperative complications and psychosocial reintegration of the patients into their families and societies.</p><p><strong>Results and limitations: </strong>Vesicovaginal fistulas accounted for 64% of cases, followed by urethrovaginal (12%) and rectovaginal (11%). Obstetric trauma and iatrogenic injury were the leading causes (59% and 34%, respectively). Fistulas were classified as simple (36%), recurrent (56%), or complex (8%). Overall closure rate was 82%, highest among simple (91%) and primary (85%) cases. Adjuncts such as platelet-rich plasma (PRP), small intestinal submucosa (SIS), fibrin glue, and buccal grafts were used in 71% of complex/recurrent repairs, with a 72% closure rate in this subgroup. Residual incontinence after successful closure of fistula affected 12% of patients, most of whom improved with bulking agents (72%) or pubovaginal slings (91%). Complication rates included urinary tract and wound infections (5%) and recurrence of fistula (18%). Limitations include retrospective design and heterogeneity in adjunct usage. Another main limitation is our follow-up regimen, which was not done by our surgical team in all countries included. Nevertheless, treatment of residual incontinence was not performed solely by our team, and thus this affected success rate of residual incontinence.</p><p><strong>Conclusions: </strong>Combining traditional surgical methods with adjunctive techniques enables high closure and functional recovery rates in FGF repair, even in low-resource settings. Selective use of adjuncts supports tissue healing in complex cases and may enhance long-term success.</p><p><strong>Patient summary: </strong>In this multinational study of 1185 FGF surgeries, integrating traditional and innovative techniques led to high closure rates and improved continence and quality of life even in resource-constrained countries.</p><p><strong>Clinical registration: </strong>This study does not require clinical trial registration as it is an observational, retrospective analysis of anonymized surgical cases (2009-2025).</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146106617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurourology and Urodynamics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1